This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Eli Lilly and Company. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Exploring the Inventive Mind of Matthew Scott Dowling
Introduction:
Matthew Scott Dowling, a prolific inventor based in Irvine, CA, has made significant contributions to the field of pharmaceuticals with his innovative patents.
Latest Patents:
Matthew Scott Dowling holds a groundbreaking patent titled "Compounds and methods for modulating FXR." The patent discloses compounds and their pharmaceutical compositions, specifically designed for treating dyslipidemia and related diseases.
Career Highlights:
Currently employed at Eli Lilly and Company, Matthew Scott Dowling's dedication to research and development has led to the successful filing of multiple patents in the pharmaceutical sector.
Collaborations:
Throughout his career, Matthew Scott Dowling has collaborated with esteemed colleagues such as Michael Gregory Bell and Robert Anthony Doti. Together, they have worked on various projects aimed at advancing healthcare technologies.
Conclusion:
In conclusion, Matthew Scott Dowling's innovative spirit and commitment to advancing pharmaceutical research make him a standout inventor in the field. His contributions pave the way for novel treatment options and have a significant impact on the medical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile